Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
120 hedge funds and large institutions have $452M invested in Amedisys in 2014 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 42 increasing their positions, 44 reducing their positions, and 16 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
4% more capital invested
Capital invested by funds: $434M → $452M (+$18.2M)
5% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 44
4% less funds holding
Funds holding: 125 → 120 (-5)
25% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 16
49% less call options, than puts
Call options by funds: $1.92M | Put options by funds: $3.74M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JCG
JHL Capital Group
Chicago,
Illinois
|
+$9.23M |
| 2 |
DM
Deerfield Management
New York
|
+$6.76M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.86M |
| 4 |
Renaissance Technologies
New York
|
+$2.23M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.79M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$3.44M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$3.25M |
| 3 |
Two Sigma Investments
New York
|
-$1.26M |
| 4 |
Goldman Sachs
New York
|
-$931K |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$881K |
AMED Hedge Fund Activity: Q1 2014 in Review
120 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q1 2014, worth a combined $452M — up 4.2% from $434M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of AMED and 12 opened new positions — a net loss of 4 holders — while 44 trimmed existing stakes and 42 added.
The largest buyer was JHL Capital Group, opening a new position worth an estimated $9.23M. The largest seller was Wells Fargo, cutting an estimated $3.44M.
- 120 institutional investors held Amedisys (AMED) as of Q1 2014, down from 125 in Q4 2013.
- Funds reported $452M of Amedisys stock for Q1 2014, up 4.2% quarter-over-quarter.
- 12 funds opened new Amedisys positions in Q1 2014 and 16 closed out, a net change of -4 holders.
- The largest Amedisys buyer in Q1 2014 was JHL Capital Group, an estimated $9.23M added.
- The largest Amedisys seller in Q1 2014 was Wells Fargo, an estimated $3.44M sold.
Based on aggregated 13F filings for Q1 2014.